A human monoclonal IgG1 potently neutralizing the pro-inflammatory cytokine GM-CSF

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 916-925

  Krinner, Eva Maria ^a   Raum, Tobias ^a   Petsch, Silke ^a   Bruckmaier, Sandra ^a   Schuster, Ioana ^a   Petersen, Laetitia ^a   Cierpka, Ronny ^a   Abebe, Derege ^a   Mølhøj, Michael ^a   Wolf, Andreas ^a   Sørensen, Poul ^a   Locher, Mathias ^a   Baeuerle, Patrick A ^a   Hepp, Julia ^a  

^a MICROMET AG   (Germany)

Author keywords

Cytokine; Eosinophil; GM CSF; Inflammation; Monoclonal antibody; Treatment

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY MT 203; MT 203; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; EOSINOPHIL; EPITHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; INFLAMMATORY DISEASE; LUNG; MACACA; PHAGE DISPLAY; PNEUMONIA; PRIORITY JOURNAL; SERUM; YEAST;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; EOSINOPHILS; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-1BETA; INTERLEUKIN-8; LECTINS, C-TYPE; MACACA;

ANIMALIA; ESCHERICHIA COLI;

EID: 33748800252     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.03.020     Document Type: Article

References (30)

1. Bozinovski S., Jones J., Beavitt S.J., Cook A.D., Hamilton J.A., and Anderson G.P. Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4. Am. J. Physiol. Lung Cell. Mol. Physiol. 286 (2004) L877-L885
2. Bozinovski S., Jones J.E., Vlahos R., Hamilton J.A., and Anderson G.P. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo. J. Biol. Chem. 277 (2002) 42808-42814
3. Campbell I.K., Rich M.J., Bischof R.J., Dunn A.R., Grail D., and Hamilton J.A. Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. J. Immunol. 161 (1998) 3639-3644
4. Cates E.C., Fattouh R., Wattie J., Inman M.D., Goncharova S., Coyle A.J., Gutierrez-Ramos J.C., and Jordana M. Intranasal exposure of mice to house dust mite elicits allergic airway inflammation via a GM-CSF-mediated mechanism. J. Immunol. 173 (2004) 6384-6392
5. Cates E.C., Gajewska B.U., Goncharova S., Alvarez D., Fattouh R., Coyle A.J., Gutierrez-Ramos J.C., and Jordana M. Effect of GM-CSF on immune, inflammatory, and clinical responses to ragweed in a novel mouse model of mucosal sensitization. J. Allergy Clin. Immunol. 111 (2003) 1076-1086
6. Cebon J., Nicola N., Ward M., Gardner I., Dempsey P., Layton J., Duhrsen U., Burgess A.W., Nice E., and Morstyn G. Granulocyte-macrophage colony stimulating factor from human lymphocytes. The effect of glycosylation on receptor binding and biological activity. J. Biol. Chem. 265 (1990) 4483-4491
7. Cook A.D., Braine E.L., Campbell I.K., Rich M.J., and Hamilton J.A. Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease. Arthritis Res. 3 (2001) 293-298
8. de Vries E.G., Willemse P.H., Biesma B., Stern A.C., Limburg P.C., and Vellenga E. Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy. Lancet 338 (1991) 517-518
9. Diederichs K., Boone T., and Karplus P.A. Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor. Science 254 (1991) 1779-1782
10. Esnault S., and Malter J.S. GM-CSF regulation in eosinophils. Arch. Immunol. Ther. Exp. (Warsz.) 50 (2002) 121-130
11. Fiehn C., Wermann M., Pezzutto A., Hufner M., and Heilig B. Plasma GM-CSF concentrations in rheumatoid arthritis, systemic lupus erythematosus and spondyloarthropathy. Z. Rheumatol. 51 (1992) 121-126
12. Gajewska B.U., Wiley R.E., and Jordana M. GM-CSF and dendritic cells in allergic airway inflammation: basic mechanisms and prospects for therapeutic intervention. Curr. Drug Targets Inflamm. Allergy 2 (2003) 279-292
13. Hamilton J.A. GM-CSF in inflammation and autoimmunity. Trends Immunol. 23 (2002) 403-408
14. Hercus T.R., Cambareri B., Dottore M., Woodcock J., Bagley C.J., Vadas M.A., Shannon M.F., and Lopez A.F. Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor. Blood 83 (1994) 3500-3508
15. Humbles A.A., Lloyd C.M., McMillan S.J., Friend D.S., Xanthou G., McKenna E.E., Ghiran S., Gerard N.P., Yu C., Orkin S.H., and Gerard C. A critical role for eosinophils in allergic airways remodeling. Science 305 (2004) 1776-1779
16. Kankaanranta H., Lindsay M.A., Giembycz M.A., Zhang X., Moilanen E., and Barnes P.J. Delayed eosinophil apoptosis in asthma. J. Allergy Clin. Immunol. 106 (2000) 77-83
17. Kotsimbos A.T., Humbert M., Minshall E., Durham S., Pfister R., Menz G., Tavernier J., Kay A.B., and Hamid Q. Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma. J. Allergy Clin. Immunol. 99 (1997) 666-672
18. Lampinen M., Carlson M., Hakansson L.D., and Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 59 (2004) 793-805
19. Lantero S., Sacco O., Scala C., and Rossi G.A. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF. J. Asthma 34 (1997) 141-152
20. McQualter J.L., Darwiche R., Ewing C., Onuki M., Kay T.W., Hamilton J.A., Reid H.H., and Bernard C.C. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194 (2001) 873-882
21. Openshaw H., Stuve O., Antel J.P., Nash R., Lund B.T., Weiner L.P., Kashyap A., McSweeney P., and Forman S. Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology 54 (2000) 2147-2150
22. Raum T., Gruber R., Riethmuller G., and Kufer P. Anti-self antibodies selected from a human IgD heavy chain repertoire: a novel approach to generate therapeutic human antibodies against tumor-associated differentiation antigens. Cancer Immunol. Immunother. 50 (2001) 141-150
23. Santiago-Schwarz F., Anand P., Liu S., and Carsons S.E. Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate Th1 inflammatory-type responses. J. Immunol. 167 (2001) 1758-1768
24. Schon M., Denzer D., Kubitza R.C., Ruzicka T., and Schon M.P. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J. Invest. Dermatol. 114 (2000) 976-983
25. Schwartzman S., Fleischmann R., and Morgan Jr. G.J. Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?. Arthritis Res. Ther. 6 Suppl. 2 (2004) S3-S11
26. Sheridan J.W., and Metcalf D. A low molecular weight factor in lung-conditioned medium stimulating granulocyte and monocyte colony formation in vitro. J. Cell. Physiol. 81 (1973) 11-23
27. Sousa A.R., Poston R.N., Lane S.J., Nakhosteen J.A., and Lee T.H. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am. Rev. Respir. Dis. 147 (1993) 1557-1561
28. Woolley K.L., Adelroth E., Woolley M.J., Ellis R., Jordana M., and O'Byrne P.M. Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma. Eur. Respir. J. 7 (1994) 1576-1584
29. Xu J., Lucas R., Schuchmann M., Kuhnle S., Meergans T., Barreiros A.P., Lohse A.W., Otto G., and Wendel A. GM-CSF restores innate, but not adaptive, immune responses in glucocorticoid-immunosuppressed human blood in vitro. J. Immunol. 171 (2003) 938-947
30. Yamashita N., Tashimo H., Ishida H., Kaneko F., Nakano J., Kato H., Hirai K., Horiuchi T., and Ohta K. Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). Cell. Immunol. 219 (2002) 92-97